Coya is developing disruptive, first in class, autologous regulatory T-cell (Treg) and allogeneic exosome therapies - leveraging the seminal discoveries from the laboratory of Stanley Appel M.D., in which dysfunctional Tregs modulate neurodegenerative and autoimmune diseases.

Biotechnology

Education

Coya Therapeutics

Coya Therapeutics' headquarters in Houston, TX, United States

Howard Berman

Fred Grossman D.O., FAPA

Arun Swaminathan

David S. Snyder

Gregory MacMichael

Aaron Thome

Stanley Appel

Clive Svendsen

Lawrence Steinman

Anabella Villalobos

Dov Goldstein

Ann Lee

Malcolm Brenner

Shimon Sakaguchi

Hideki Garren

Description

People (3)

Howard Berman

Aaron Thome

Daniel Barvin

Jobs